229 related articles for article (PubMed ID: 19596786)
1. ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo.
Muraoka-Cook RS; Sandahl MA; Strunk KE; Miraglia LC; Husted C; Hunter DM; Elenius K; Chodosh LA; Earp HS
Mol Cell Biol; 2009 Sep; 29(18):4935-48. PubMed ID: 19596786
[TBL] [Abstract][Full Text] [Related]
2. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.
Muraoka-Cook RS; Sandahl M; Husted C; Hunter D; Miraglia L; Feng SM; Elenius K; Earp HS
Mol Biol Cell; 2006 Sep; 17(9):4118-29. PubMed ID: 16837552
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation.
Feng SM; Muraoka-Cook RS; Hunter D; Sandahl MA; Caskey LS; Miyazawa K; Atfi A; Earp HS
Mol Cell Biol; 2009 Feb; 29(3):892-906. PubMed ID: 19047365
[TBL] [Abstract][Full Text] [Related]
4. Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation.
Muraoka-Cook RS; Sandahl M; Hunter D; Miraglia L; Earp HS
Mol Endocrinol; 2008 Oct; 22(10):2307-21. PubMed ID: 18653779
[TBL] [Abstract][Full Text] [Related]
5. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation.
Jones FE; Welte T; Fu XY; Stern DF
J Cell Biol; 1999 Oct; 147(1):77-88. PubMed ID: 10508857
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients.
Machleidt A; Buchholz S; Diermeier-Daucher S; Zeman F; Ortmann O; Brockhoff G
BMC Cancer; 2013 Sep; 13():437. PubMed ID: 24063248
[TBL] [Abstract][Full Text] [Related]
7. The HER4 isoform JM-a/CYT2 relates to improved survival in bladder cancer patients but only if the estrogen receptor α is not expressed.
Munk M; Memon A; Poulsen SS; Borre M; Nexo E; Sorensen BS
Scand J Clin Lab Invest; 2013 Sep; 73(6):503-13. PubMed ID: 24015958
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
[TBL] [Abstract][Full Text] [Related]
9. ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration.
Gambarotta G; Garzotto D; Destro E; Mautino B; Giampietro C; Cutrupi S; Dati C; Cattaneo E; Fasolo A; Perroteau I
J Biol Chem; 2004 Nov; 279(47):48808-16. PubMed ID: 15355992
[TBL] [Abstract][Full Text] [Related]
10. ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation.
Williams MM; Vaught DB; Joly MM; Hicks DJ; Sanchez V; Owens P; Rahman B; Elion DL; Balko JM; Cook RS
Breast Cancer Res; 2017 Sep; 19(1):105. PubMed ID: 28886748
[TBL] [Abstract][Full Text] [Related]
11. The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.
Kiuchi T; Ortiz-Zapater E; Monypenny J; Matthews DR; Nguyen LK; Barbeau J; Coban O; Lawler K; Burford B; Rolfe DJ; de Rinaldis E; Dafou D; Simpson MA; Woodman N; Pinder S; Gillett CE; Devauges V; Poland SP; Fruhwirth G; Marra P; Boersma YL; Plückthun A; Gullick WJ; Yarden Y; Santis G; Winn M; Kholodenko BN; Martin-Fernandez ML; Parker P; Tutt A; Ameer-Beg SM; Ng T
Sci Signal; 2014 Aug; 7(339):ra78. PubMed ID: 25140053
[TBL] [Abstract][Full Text] [Related]
12. ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events.
Clark DE; Williams CC; Duplessis TT; Moring KL; Notwick AR; Long W; Lane WS; Beuvink I; Hynes NE; Jones FE
J Biol Chem; 2005 Jun; 280(25):24175-80. PubMed ID: 15863494
[TBL] [Abstract][Full Text] [Related]
13. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5.
Long W; Wagner KU; Lloyd KC; Binart N; Shillingford JM; Hennighausen L; Jones FE
Development; 2003 Nov; 130(21):5257-68. PubMed ID: 12954715
[TBL] [Abstract][Full Text] [Related]
14. Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo.
Nielsen TO; Sorensen S; Dagnæs-Hansen F; Kjems J; Sorensen BS
Br J Cancer; 2013 Jun; 108(11):2291-8. PubMed ID: 23695025
[TBL] [Abstract][Full Text] [Related]
15. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.
Muraoka-Cook RS; Feng SM; Strunk KE; Earp HS
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):235-46. PubMed ID: 18437540
[TBL] [Abstract][Full Text] [Related]
16. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.
Teulière J; Faraldo MM; Deugnier MA; Shtutman M; Ben-Ze'ev A; Thiery JP; Glukhova MA
Development; 2005 Jan; 132(2):267-77. PubMed ID: 15590737
[TBL] [Abstract][Full Text] [Related]
17. CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy.
Mapes J; Li Q; Kannan A; Anandan L; Laws M; Lydon JP; Bagchi IC; Bagchi MK
PLoS Genet; 2017 Mar; 13(3):e1006654. PubMed ID: 28278176
[TBL] [Abstract][Full Text] [Related]
18. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.
Vidal GA; Naresh A; Marrero L; Jones FE
J Biol Chem; 2005 May; 280(20):19777-83. PubMed ID: 15746097
[TBL] [Abstract][Full Text] [Related]
19. Mammary gland-specific nuclear factor activity is positively regulated by lactogenic hormones and negatively by milk stasis.
Schmitt-Ney M; Happ B; Hofer P; Hynes NE; Groner B
Mol Endocrinol; 1992 Dec; 6(12):1988-97. PubMed ID: 1491685
[TBL] [Abstract][Full Text] [Related]
20. Developmental stage determines the effects of MYC in the mammary epithelium.
Blakely CM; Sintasath L; D'Cruz CM; Hahn KT; Dugan KD; Belka GK; Chodosh LA
Development; 2005 Mar; 132(5):1147-60. PubMed ID: 15689376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]